Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients.
Chak
W L
WL
Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China. chakwaileung@hotmail.com
Choi
K S
KS
Wong
K M
KM
Chan
Y H
YH
Chau
K F
KF
Li
C S
CS
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D002681:China; D003365:Costs and Cost Analysis; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology / Q000821:virology; D012008:Recurrence; D012189:Retrospective Studies; D013997:Time Factors
D000998:Antiviral Agents; D015774:Ganciclovir